ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1019

Involvement of Mast Cells in the Pathogenesis of Sjögren’s Syndrome By Induction of Tissue Fibrosis Via Fibroblast Collagen Synthesis

Shinjiro Kaieda1, Kyoko Fujimoto2, Masaki Tominaga3, Masaki Okamoto4, Tomoaki Hoshino5 and Hiroaki Ida6, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 3Kurume University School of Medicine, Kurume, Japan, 4Medicine, Kurume University School of Medicine, Kurume, Japan, 5Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 6Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Collagen, fibrosis and mast cells, Sjӧgrens

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Innate Immunity Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is an emerging view that mast cells may play a pivotal role in several inflammatory and autoimmune diseases. However, the role of mast cells in Sjögren’s syndrome remains unclear. We examined whether mast cells play a critical role in immune-mediated inflammation and fibrosis in patients with Sjögren’s syndrome.

Methods:

Labial salivary gland samples were collected from 22 individuals with primary Sjögren’s syndrome and 10 with sicca syndrome (controls) and were examined using histological and immunohistochemical methods.Saliva production was evaluated by Saxon’s test. Mast cell density in the minor salivary glands was calculated at x400 magnification. Five fields were counted in all cases. The lymphocyte focus score was evaluated based on the number of inflammatory cell aggregates containing >50 lymphocytes per 4 mm2. The degree of fibrosis in the minor labial salivary glands was graded on a quantitative scale as previously reported (Clin Exp Rheumatol.1998;16:63-65). We used immunohistochemistry to identify and quantify tryptase-positive mast cells and vimentin-positive fibroblasts. Fibrous tissue was identified using elastic Van Gieson (EVG) staining. Human mast cell line 1 (HMC-1) cells were cocultured with pulmonary fibroblasts for 7 days using a transwell system, and type I collagen synthesis in fibroblasts was evaluated by quantitative RT-PCR.

Results: We found that the number of mast cells in the labial salivary glands of patients with primary Sjögren’s syndrome was significantly increased compared to that in control subjects (p<0.0001). There was a significant negative correlation between the Saxon’s test results and the number of mast cells (r= -0.6742, p=0.006), suggesting the involvement of mast cells in the decreased salivary secretion. There was no significant correlation between the intensity of lymphoid infiltration assessed by the focus score and the mast cell density (r=0.01545, p=0.58). In contrast, a significant correlation between the number of mast cells and the degree of fibrosis was observed (r= 0.5911, p=0.0038). Consistent with these findings, histochemical analysis revealed that mast cells were usually present in close proximity to EVG-stained fibrous tissue in the labial salivary glands. Furthermore, double immunostaining revealed that the mast cells were located proximal to vimentin-positive fibroblasts. We hypothesized that mast cells were involved in the development of tissue fibrosis via modulation of fibroblast immune function in sialadenitis and conducted an in vitro co-culture of HMC-1 cells and pulmonary fibroblasts. Significant up-regulation of Col1a mRNA was observed in fibroblasts co-cultured with HMC-1 cells compared to that in fibroblast monocultures (p=0.02).

Conclusion: These results suggest a novel role for mast cells in the development of sialadenitis in patients with primary Sjögren’s syndrome by induction of tissue fibrosis via fibroblast collagen synthesis.


Disclosure: S. Kaieda, None; K. Fujimoto, None; M. Tominaga, None; M. Okamoto, None; T. Hoshino, None; H. Ida, None.

To cite this abstract in AMA style:

Kaieda S, Fujimoto K, Tominaga M, Okamoto M, Hoshino T, Ida H. Involvement of Mast Cells in the Pathogenesis of Sjögren’s Syndrome By Induction of Tissue Fibrosis Via Fibroblast Collagen Synthesis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/involvement-of-mast-cells-in-the-pathogenesis-of-sjogrens-syndrome-by-induction-of-tissue-fibrosis-via-fibroblast-collagen-synthesis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-mast-cells-in-the-pathogenesis-of-sjogrens-syndrome-by-induction-of-tissue-fibrosis-via-fibroblast-collagen-synthesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology